Physician profile
Jesse Selber
NPI 1417013384
$180,562.77
in general payments reported to CMS, 2019-2025
37 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $23K · 2021: $24K · 2022: $34K · 2023: $19K · 2024: $33K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $52K · Food and Beverage: $13K · Travel and Lodging: $6,793 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $600 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,368.40 |
| Food and Beverage | $12,840.60 |
| Travel and Lodging | $6,792.52 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $600.00 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $112,631.87 | 2019-2025 | Integra, Omnigraft, Surgimend |
| Medical Microinstruments, INC. | $24,358.46 | 2024 | Symani Surgical Sistem, Symani Surgical Systems |
| Intuitive Surgical, INC. | $17,072.49 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $5,161.14 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Tei Biosciences INC | $3,736.64 | 2019 | |
| Mentor Worldwide LLC | $2,786.79 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Allergan, INC. | $2,603.11 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,980.30 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $1,669.59 | 2019-2022 | |
| Kerecis Limited | $1,444.46 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Sientra, INC. | $1,212.09 | 2019-2022 | |
| Depuy Synthes Sales INC. | $824.15 | 2019-2025 | Trumatch, Matrixrib |
| Davol INC. | $785.43 | 2019-2025 | Phasix Mesh |
| Organogenesis INC. | $633.53 | 2024-2025 | Cygnus Matrix, Nushield |
| Abbvie INC. | $615.52 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $418.06 | 2022-2023 | Celleraterx |
| Baxter Healthcare | $294.75 | 2019-2022 | |
| Polynovo North America LLC | $292.57 | 2024-2025 | Novosorb Btm |
| Axogen | $266.80 | 2023-2025 | Avance Nerve Graft |
| Innovation Technologies INC | $250.63 | 2022-2025 | Irrisept |
| Aroa Biosurgery Incorporated | $174.24 | 2024 | |
| Solventum Corporation | $170.88 | 2025 | Prevena |
| Bard Peripheral Vascular, INC. | $164.94 | 2021 | |
| Surgical Theater. INC. | $150.11 | 2025 | |
| Histosonics, INC. | $146.49 | 2024 | |
| Avita Medical Americas, LLC | $142.75 | 2025 | Cohealyx, Recell, Permeaderm |
| Heron Therapeutics, INC. | $122.93 | 2025 | Zynrelef |
| Mimedx Group, INC. | $84.20 | 2025 | |
| Conmed Corporation | $70.96 | 2019 | |
| Ethicon US, LLC | $70.15 | 2019 | |
| Kci USA, INC. | $67.44 | 2019 | |
| Olympus America INC. | $45.51 | 2020 | |
| Vioptix INC | $39.04 | 2019 | |
| Smith+Nephew, INC. | $26.59 | 2023 | Pico 7, Renasys Go V2 Home, Renasys Touch |
| Stryker Corporation | $26.17 | 2019 | |
| Aesculap, INC. | $13.57 | 2024 | Aesculap |
| Rti Surgical, INC | $8.42 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Selber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.